Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Selling, General & Administrative (2020 - 2026)

Updated

Nuvalent (NUVL) posted Selling, General & Administrative of $35.8 million for Q1 2026, up 75.5% from $20.39 million a year earlier and up 4.0% from the prior quarter.

Analysis

Nuvalent (NUVL) Selling, General & Administrative (2020 - 2026) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, Selling, General & Administrative at Nuvalent was $122.74 million, up 77.8% year-over-year; for FY2025, it came in at $107.34 million, up 71.5% from FY2024.

  • Annual Selling, General & Administrative has increased for five consecutive years, with a five-year compound annual growth rate of 134.9% (FY2020 to FY2025).
  • In prior years, Nuvalent's Selling, General & Administrative was $62.59 million in FY2024 (+72.7%), $36.25 million in FY2023 (+62.0%), $22.38 million in FY2022 (+118.1%) and $10.26 million in FY2021 (+583.0%).
  • The Q1 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to Q2 2020.
  • On a year-over-year basis, Selling, General & Administrative has increased in each of the last 20 quarters, with growth averaging 72.6% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 46.2% (Q1 2025) to 957.1% (Q3 2021).
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $34.43 million (Q4 2025), $28.85 million (Q3 2025) and $23.66 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Nuvalent 9.75 Bn 9.75 Bn - 35.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 35.80 Mn
Dec 31, 2025 34.43 Mn
Sep 30, 2025 28.85 Mn
Jun 30, 2025 23.66 Mn
Mar 31, 2025 20.39 Mn
Dec 31, 2024 16.88 Mn
Sep 30, 2024 15.78 Mn
Jun 30, 2024 15.98 Mn
Mar 31, 2024 13.95 Mn
Dec 31, 2023 10.85 Mn
Sep 30, 2023 9.17 Mn
Jun 30, 2023 8.14 Mn
Mar 31, 2023 8.09 Mn
Dec 31, 2022 6.44 Mn
Sep 30, 2022 5.76 Mn
Jun 30, 2022 5.18 Mn
Mar 31, 2022 5.00 Mn
Dec 31, 2021 4.18 Mn
Sep 30, 2021 3.37 Mn
Jun 30, 2021 2.02 Mn
API Access

Nuvalent Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NUVL&period=max&api_key=YOUR_API_KEY